Tandon School of Engineering

Research output

Research output per year 1963 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 10537 Article
• 6561 Conference contribution
• 779 Conference article
• 636 Chapter
• 3007 More
  • 579 Comment/debate
  • 496 Paper
  • 446 Chapter (peer-reviewed)
  • 441 Review article
  • 350 Editorial
  • 228 Book
  • 182 Other report
  • 92 Letter
  • 43 Book/Film/Article review
  • 40 Abstract
  • 24 Short survey
  • 22 Special issue
  • 21 Entry for encyclopedia/dictionary
  • 20 Foreword/postscript
  • 8 Other contribution
  • 4 Digital or Visual Products
  • 4 Preprint
  • 2 Scholarly edition
  • 2 Working paper
  • 1 Other chapter contribution
  • 1 Literature review
  • 1 Patent

Research output per year

Research output per year

Search results

• 2016

  Re: Expectant Management of Veterans with Early-Stage Prostate Cancer

  Taneja, S. S., Sep 1 2016, In: The Journal of urology. 196, 3, p. 743-744 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Adverse Health Events following Intermittent and Continuous Androgen Deprivation in Patients with Metastatic Prostate Cancer

  Taneja, S. S., Aug 1 2016, In: The Journal of urology. 196, 2, p. 412-414 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Androgen receptor splice variant 7 and efficacy of taxane chemotherapy in patients with metastatic castration-resistant prostate cancer: Editorial comment

  Taneja, S. S., May 1 2016, In: Journal of Urology. 195, 5, p. 1472-1473 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Medium-Term Outcomes after Whole-Gland High-Intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort

  Taneja, S. S., Jul 1 2016, In: The Journal of urology. 196, 1, p. 103-104 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Nine-Year Follow-up for a Study of Diffusion-Weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort

  Taneja, S. S., Jun 1 2016, In: Journal of Urology. 195, 6, p. 1781-1782 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Difference in Association of Obesity with Prostate Cancer Risk between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

  Taneja, S. S., Mar 1 2016, In: The Journal of urology. 195, 3, p. 627-628 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Hypofractionated Radiotherapy versus Conventionally Fractionated Radiotherapy for Patients with Intermediate-Risk Localised Prostate Cancer: 2-Year Patient-Reported Outcomes of the Randomised, Non-Inferiority, Phase 3 CHHiP Trial

  Taneja, S. S., Nov 1 2016, In: The Journal of urology. 196, 5, p. 1445-1447 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Dose-Escalated Irradiation and Overall Survival in Men with Nonmetastatic Prostate Cancer

  Taneja, S. S., Mar 1 2016, In: The Journal of urology. 195, 3, 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Gleason Misclassification Rate is Independent of Number of Biopsy Cores in Systematic Biopsy

  Taneja, S. S., Aug 1 2016, In: The Journal of urology. 196, 2, p. 413-414 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Long-term follow-up of a randomized trial of radiation with or without androgen deprivation therapy for localized prostate cancer: Editorial comment

  Taneja, S. S., May 1 2016, In: Journal of Urology. 195, 5, p. 1471-1473 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Prostate-Specific Antigen Decline after 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer

  Taneja, S. S., Jul 1 2016, In: The Journal of urology. 196, 1, 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations

  Taneja, S. S., Apr 1 2016, In: The Journal of urology. 195, 4, p. 926-927 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: A Prospective Development Study

  Taneja, S. S., Aug 1 2016, In: The Journal of urology. 196, 2, p. 414 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review
• 2015

  Erratum: Radio propagation path loss models for 5g cellular networks in the 28 ghz and 38 ghz millimeter-wave bands (IEEE Communications Magazine (2014) 52: 9 (78-86))

  Sulyman, A. I., Nassar, A. M. T., Samimi, M. K., MacCartney, G. R., Rappaport, T. S. & Alsanie, A., Jan 1 2015, In: IEEE Communications Magazine. 53, 1, p. 303 1 p., 7010549.

  Research output: Contribution to journal › Comment/debate › peer-review

• Erratum: Hydroelastic impact of piezoelectric structures (International Journal of Impact Engineering (2014) 66 (18-27))

  Panciroli, R. & Porfiri, M., Jul 1 2015, In: International Journal of Impact Engineering. 81, p. 74-75 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Erratum to: Metal- and Polymer-Matrix Composites: Functional Lightweight Materials for High-Performance Structures [JOM, 66, 6, (2014), DOI:10.1007/s11837-014-0969-0]

  Gupta, N. & Paramsothy, M., Aug 27 2015, In: JOM. 67, 8, 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Measuring blood flow so what?

  Schuman, J. S., Sep 1 2015, In: JAMA ophthalmology. 133, 9, p. 1052-1053 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Re: Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial

  Taneja, S. S., Mar 1 2015, In: Journal of Urology. 193, 3, p. 848-849 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer

  Taneja, S. S., 2015, In: Journal of Urology. 194, 1, p. 112-115 4 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: A phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: Background and rationale of the radiotherapydadjuvant versus early salvage (RAVES) trial: Editorial comment

  Taneja, S. S., Feb 1 2015, In: Journal of Urology. 193, 2, p. 538 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Phase III, randomized, double-blind, multicenter trial comparing orteronel (TAK-700) plus prednisone with placebo plus prednisone in patients with metastatic castration-resistant prostate cancer that has progressed during or after docetaxel-based therapy: ELM-PC 5

  Taneja, S. S., Oct 1 2015, In: Journal of Urology. 194, 4, 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer: Editorial comment

  Taneja, S. S., Feb 1 2015, In: Journal of Urology. 193, 2, p. 538-540 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Organoid cultures derived from patients with advanced prostate cancer

  Taneja, S. S., Apr 1 2015, In: Journal of Urology. 193, 4, p. 1442-1443 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: A biopsy-based 17-gene genomic prostate score predicts recurrence after radical prostatectomy and adverse surgical pathology in a racially diverse population of men with clinically low- and intermediate-risk prostate cancer: Editorial comment

  Taneja, S. S., May 1 2015, In: Journal of Urology. 193, 5, p. 1541 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-Specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study: Editorial Comment

  Taneja, S. S., 2015, In: Journal of Urology. 194, 2, p. 393-394 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Adjuvant and salvage radiotherapy after prostatectomy: American society of clinical oncology clinical practice guideline endorsement: Editorial comment

  Taneja, S. S., May 1 2015, In: Journal of Urology. 193, 5, p. 1539-1541 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy

  Taneja, S. S., Sep 1 2015, In: Journal of Urology. 194, 3, p. 704-705 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Salvage high-intensity focused ultrasound for patients with recurrent prostate cancer after brachytherapy

  Taneja, S. S., 2015, In: Journal of Urology. 194, 1, 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: Does timing matter?

  Taneja, S. S., Sep 1 2015, In: Journal of Urology. 194, 3, 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: Is adjuvant radiation warranted?

  Taneja, S. S., Dec 2015, In: Journal of Urology. 194, 6, p. 1631-1632 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Long-Term Follow-up of a Large Active Surveillance Cohort of Patients with Prostate Cancer

  Taneja, S. S., Nov 2015, In: Journal of Urology. 194, 5, p. 1286 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Screening and Prostate Cancer Mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 Years of Follow-up: Editorial Comment

  Taneja, S. S., 2015, In: Journal of Urology. 194, 2, p. 392-394 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Verification of EAU Guideline Criteria: Editorial Comment

  Taneja, S. S., 2015, In: Journal of Urology. 194, 2, p. 394 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Androgen receptor gene aberrations in circulating cell-free DNA: Biomarkers of therapeutic resistance in castration-resistant prostate cancer

  Taneja, S. S., Sep 1 2015, In: Journal of Urology. 194, 3, p. 704 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): A randomised, controlled, phase 3 trial

  Taneja, S. S., Oct 1 2015, In: Journal of Urology. 194, 4, p. 989-990 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Predicting high-grade cancer at ten-core prostate biopsy using four Kallikrein Markers measured in blood in the protect study

  Taneja, S. S., Dec 2015, In: Journal of Urology. 194, 6, p. 1632 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: Results from a phase 3, double-blind, randomised trial

  Taneja, S. S., Mar 1 2015, In: Journal of Urology. 193, 3, p. 847-848 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Effect of Enzalutamide on Time to First Skeletal-Related Event, Pain, and Quality of Life in Men with Castration-Resistant Prostate Cancer: Results from the Randomised, Phase 3 AFFIRM Trial: Editorial Comment

  Taneja, S. S., 2015, In: Journal of Urology. 194, 2, p. 392-393 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Do environmental factors modify the genetic risk of prostate cancer?: Editorial comment

  Taneja, S. S., May 1 2015, In: Journal of Urology. 193, 5, p. 1540 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Can urinary PCA3 supplement PSA in the early detection of prostate cancer?

  Taneja, S. S., 2015, In: Journal of Urology. 194, 1, p. 115 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer

  Taneja, S. S., Sep 1 2015, In: Journal of Urology. 194, 3, p. 703-705 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Are elderly patients with clinically localized prostate cancer overtreated? Exploring heterogeneity in survival effects

  Taneja, S. S., Apr 1 2015, In: Journal of Urology. 193, 4, p. 1252-1253 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Diffusion-weighted MR imaging in early assessment of tumor response to radiotherapy in high-risk prostate cancer: Editorial comment

  Taneja, S. S., Feb 1 2015, In: Journal of Urology. 193, 2, p. 539-540 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy

  Taneja, S. S., Nov 2015, In: Journal of Urology. 194, 5, p. 1285-1286 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Cost-effectiveness of prostate cancer screening: A simulation study based on ERSPC data

  Taneja, S. S., 2015, In: Journal of Urology. 194, 1, p. 113-114 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Does discontinuous involvement of a prostatic needle biopsy core by adenocarcinoma correlate with a large tumor focus at radical prostatectomy?

  Taneja, S. S., Apr 1 2015, In: Journal of Urology. 193, 4, p. 1252-1253 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: The impact of fellowship training on pathological outcomes following radical prostatectomy: A population based analysis: Editorial comment

  Taneja, S. S., May 1 2015, In: Journal of Urology. 193, 5, p. 1539-1540 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Re: Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer

  Taneja, S. S., Mar 1 2015, In: Journal of Urology. 193, 3, p. 847-849 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review
• 2014

  Averting the perfect storm: Addressing youth substance use risk from social media use

  Salimian, P. K., Chunara, R. & Weitzman, E. R., Oct 1 2014, In: Pediatric annals. 43, 10, p. e242-e247

  Research output: Contribution to journal › Comment/debate › peer-review

  • Substance Abuse 100%
  • Epileptic Absence 100%
  • Adolescents 100%
  • Perfect Storm 100%
  • Media Use 100%

• Editorial comment

  Taneja, S. S., Feb 2014, In: Journal of Urology. 191, 2, p. 360 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review